Transplant represents an effective strategy in the management of chronic organ dysfunction.
Nonetheless, life threatening risks remain, especially in the post-transplant; among them …

Cytomegalovirus (CMV) is one of the most important pathogens that infect solid organ
transplant recipients. CMV is associated with increased morbidity and mortality in this …

Background Scant information is available about how transplant centers are managing their
use of quantitative molecular testing (QNAT) assays for active cytomegalovirus (CMV) …

Cytomegalovirus (CMV) remains a major cause of morbidity and mortality in allogeneic
hematopoietic stem cell transplantation (allo‐HSCT) and solid organ transplantation (SOT) …

Cytomegalovirus infection remains a major complication of solid organ transplantation. In
2005 the Spanish Transplantation Infection Study Group (GESITRA) of the Spanish Society …

Abstract Purpose of Review Immune monitoring to determine when and how the recovery of
cytomegalovirus (CMV)-specific T-cells occurs post-transplantation may help clinicians to …

Human cytomegalovirus (HCMV) still causes major viral complications in the post-transplant
period of both solid-organ (SO) and hematopoietic stem cell (HSC) transplant (T) recipients …

Cytomegalovirus (CMV) infection remains an important complication of transplantation. The
last decade has been characterized by improvements to management that has reduced its …

Despite improved treatment, surveillance, and prevention, cytomegalovirus (CMV) is still
regarded as an important infectious pathogen after solid-organ transplantation. More than …

Objectives Molecular assays are now considered to be the 'gold standard'for assessment of
human cytomegalovirus (CMV) infection and disease in those at risk from severe associated …